格瑞妥单抗
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
CAS2413817-97-5
Storage conditionShipping with blue ice.
Security information
Product details

Gresonitamab is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody that targets CD3-positive T cells and CLDN18.2-expressing tumor cells, with potential immunostimulatory and antineoplastic activities. It activates and proliferates T-cells, leading to the lysis of CLDN18.2-expressing tumor cells, Gresonitamab can be used for the research of adenocarcinoma.

Related literature
Related
Sorry, no related items
History
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Fezolinetant
N-Boc-L-alanine Methyl Ester; Boc-Ala-OMe
Vemurafenib (PLX 4032)
Zalcitabine (ddC; Dideoxycytidine; 2',3'-Dideoxycytidine)
Thiazovivin
(S)-3-Hydroxypyrrolidine hydrochloride
Tert-butyl (R)-2-(aminomethyl)pyrrolidine-1-carboxylate hydrochloride
(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198
Pyrintegrin | PTN | N-(Cyclopropylmethyl)-4-((4-(6-hydroxy-3,4-dihydroquinolin-1(2H)-yl)pyrimidin-2-yl)amino)benzenesulfonamide